Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines

scientific article published in May 2003

Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0264-410X(02)00822-8
P698PubMed publication ID12706682

P50authorJorge Martínez-TorrecuadradaQ55091020
J. Ignacio CasalQ57416939
P2093author name stringJosé R Castón
Albert Pagès-Manté
Enric Espuña
Narcis Saubi
P433issue17-18
P921main subjectInfectious bursal disease virusQ707615
P304page(s)1952-1960
P577publication date2003-05-01
P1433published inVaccineQ7907941
P1476titleStructure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines
P478volume21

Reverse relations

cites work (P2860)
Q45385564An attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) protects piglets against HP-PRRS.
Q40272313Comparative analysis of immune responses following experimental infection of pigs with European porcine reproductive and respiratory syndrome virus strains of differing virulence
Q44919895Comparative pathogenicity of type 1 and type 2 isolates of porcine reproductive and respiratory syndrome virus (PRRSV) in a young pig infection model.
Q43534860Comparison of the virulence of European and North American genotypes of porcine reproductive and respiratory syndrome virus in experimentally infected pigs
Q45559249Cytokines and synthetic double-stranded RNA augment the T helper 1 immune response of swine to porcine reproductive and respiratory syndrome virus
Q45361920Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs
Q38824834Efficient self-assembly and protective efficacy of infectious bursal disease virus-like particles by a recombinant baculovirus co-expressing precursor polyprotein and VP4.
Q41707401Lung pathogenicity of European genotype 3 strain porcine reproductive and respiratory syndrome virus (PRRSV) differs from that of subtype 1 strains
Q42262846Phenotypic modulation and cytokine profiles of antigen presenting cells by European subtype 1 and 3 porcine reproductive and respiratory syndrome virus strains in vitro and in vivo
Q42608452Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) infection in wild boars
Q33812653Subviral particle as vaccine and vaccine platform
Q92857940Toll-like receptor agonists as adjuvants for inactivated porcine reproductive and respiratory syndrome virus (PRRSV) vaccine
Q38059059Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development

Search more.